Health Economics

Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: A multi-country analysis
Xiao Li, Lander Willem, Caroline Klint Johannesen, Arantxa Urchueguía-Fornes, Toni Lehtonen, Richard Osei-Yeboah, Heini Salo, Alejandro Orrico Sánchez, Javier Díez Domingo, Mark Jit, PROMISE investigators, Joke Bilcke, Harish Nair, Philippe Beutels

medRxiv 2024.08.06.24311440; doi: https://doi.org/10.1101/2024.08.06.24311440

Add to Selected Citations
Is the United Kingdom (UK) medicines pricing policy failing patients? The impact of terminated National Institute for Health and Care Excellence (NICE) appraisals for multi-indication products on patients
Helen Mitchell, Qian Xin, Jack Hide, Clement Halin, Swarali Sunil Tadwalkar, Sabera Hashim, Richard Hudson

medRxiv 2024.08.06.24311489; doi: https://doi.org/10.1101/2024.08.06.24311489

Add to Selected Citations
Uncertainty Quantification in Cost-effectiveness Analysis for Stochastic-based Infectious Disease Models: Insights from Surveillance on Lymphatic Filariasis
Mary Chriselda Antony Oliver, Matthew Graham, Ioanna Manolopoulou, Graham F. Medley, Lorenzo Pellis, Koen B Pouwels, Matthew Thorpe, T. Deirdre Hollingsworth

medRxiv 2024.07.31.24311315; doi: https://doi.org/10.1101/2024.07.31.24311315

Add to Selected Citations
Cost-effectiveness of the Strategies for Surveillance of Antimicrobial-resistant Gonorrhea in the US: a Modelling Study
Sofya Prakhova

medRxiv 2024.07.29.24311166; doi: https://doi.org/10.1101/2024.07.29.24311166

Add to Selected Citations
Financial Feasibility Study and policy recommendations of Incremental Modified Drugs Development by the Domestic Pharmaceutical Industry
Manthana Laichapis, Rungpetch Sakulbumrungsil, Khunjira Udomaksorn, Nusaraporn Kessomboon, Osot Nerapusee, Charkkrit Hongthong, Sitanun Poonpolsub

medRxiv 2024.07.29.24311184; doi: https://doi.org/10.1101/2024.07.29.24311184

Add to Selected Citations
Two Billion Infected: An Inexpensive Method to Measure Latent Toxoplasmosis and its Economic Consequences^*
Anja Achtziger, Carlos Alós-Ferrer, Michele Garagnani

medRxiv 2024.07.27.24311112; doi: https://doi.org/10.1101/2024.07.27.24311112

Add to Selected Citations
Lost Opportunity in Tobacco Cessation Care: Impact of Underbilling in a Large Health System
Derek J Baughman, Marcus Rauhut, Edward Anselm

medRxiv 2024.03.29.24304678; doi: https://doi.org/10.1101/2024.03.29.24304678

Add to Selected Citations
Willingness and Perceived ability to pay for Uganda’s Proposed National Health Insurance Scheme among Informal Sector workers in Iganga and Mayuge districts, Uganda: A Contingent Valuation Method
Noel Namuhani, Angela Kisakye, Suzanne N Kiwanuka

medRxiv 2024.07.24.24310952; doi: https://doi.org/10.1101/2024.07.24.24310952

Add to Selected Citations
Assessing the Impact of Non-Pharmaceutical Interventions on COVID-19: A Combined CCE and Quantile Regression Approach
Kaibalyapati Mishra

medRxiv 2023.11.27.23299097; doi: https://doi.org/10.1101/2023.11.27.23299097

Add to Selected Citations
Economic cost of suicide of culturally and linguistically diverse populations in Australia
Humaira Maheen, Chris Doran

medRxiv 2024.07.18.24310624; doi: https://doi.org/10.1101/2024.07.18.24310624

Add to Selected Citations

Health Economics

Pages